{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T20:34:32Z","timestamp":1789936472066,"version":"4.0.1"},"publisher-location":"Cham","reference-count":30,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319675909","type":"print"},{"value":"9783319675916","type":"electronic"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-3-319-67591-6_15","type":"book-chapter","created":{"date-parts":[[2017,11,17]],"date-time":"2017-11-17T05:43:15Z","timestamp":1510897395000},"page":"283-290","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Targeting TCTP with Sertraline and Thioridazine in Cancer Treatment"],"prefix":"10.1007","author":[{"given":"Robert","family":"Amson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Auclair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Karp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Telerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,18]]},"reference":[{"key":"15_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nm.2546","volume":"18","author":"R Amson","year":"2012","unstructured":"Amson R, Pece S, Lespagnol A, Vyas R, Mazzarol G, Tosoni D, Colaluca I, Viale G, Rodrigues-Ferreira S, Wynendaele J et al (2012) Reciprocal repression between P53 and TCTP. Nat Med 18:91\u201399","journal-title":"Nat Med"},{"key":"15_CR1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/CCO.0b013e32835b7d21","volume":"25","author":"R Amson","year":"2013","unstructured":"Amson R, Karp JE, Telerman A (2013) Lessons from tumor reversion for cancer treatment. Curr Opin Oncol 25:59\u201365","journal-title":"Curr Opin Oncol"},{"key":"15_CR3","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/pros.20054","volume":"60","author":"F Arcuri","year":"2004","unstructured":"Arcuri F, Papa S, Carducci A, Romagnoli R, Liberatori S, Riparbelli MG, Sanchez JC, Tosi P, del Vecchio MT (2004) Translationally controlled tumor protein (TCTP) in the human prostate and prostate cancer cells: expression, distribution, and calcium binding activity. Prostate 60:130\u2013140","journal-title":"Prostate"},{"issue":"12","key":"15_CR4","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1038\/mt.2012.155","volume":"20","author":"V Baylot","year":"2012","unstructured":"Baylot V, Katsogiannou M, Andrieu C, Taieb D, Acunzo J, Giusiano S, Fazli L, Gleave M, Garrido C, Rocchi P (2012) Targeting TCTP as a new therapeutic strategy in castration-resistant prostate cancer. Mol Ther 20(12):2244\u20132256","journal-title":"Mol Ther"},{"key":"15_CR5","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S0196-0644(00)66384-9","volume":"36","author":"DH Brendel","year":"2000","unstructured":"Brendel DH, Bodkin JA, Yang JM (2000) Massive sertraline overdose. Ann Emerg Med 36:524\u2013526","journal-title":"Ann Emerg Med"},{"key":"15_CR6","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/ijc.25322","volume":"128","author":"J Chubak","year":"2011","unstructured":"Chubak J, Boudreau DM, Rulyak SJ, Mandelson MT (2011) Colorectal cancer risk in relation to antidepressant medication use. Int J Cancer 128:227\u2013232","journal-title":"Int J Cancer"},{"key":"15_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0304-3835(00)00460-2","volume":"156","author":"S Chung","year":"2000","unstructured":"Chung S, Kim M, Choi W, Chung J, Lee K (2000) Expression of translationally controlled tumor protein mRNA in human colon cancer. Cancer Lett 156:185\u2013190","journal-title":"Cancer Lett"},{"key":"15_CR8","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/pds.1808","volume":"18","author":"PF Coogan","year":"2009","unstructured":"Coogan PF, Strom BL, Rosenberg L (2009) Antidepressant use and colorectal cancer risk. Pharmacoepidemiol Drug Saf 18:1111\u20131114","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"15_CR9","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.canlet.2014.08.026","volume":"354","author":"V Drinberg","year":"2014","unstructured":"Drinberg V, Bitcover R, Rajchenbach W, Peer D (2014) Modulating cancer multidrug resistance by sertraline in combination with a nanomedicine. Cancer Lett 354:290\u2013298","journal-title":"Cancer Lett"},{"key":"15_CR10","doi-asserted-by":"publisher","first-page":"53137","DOI":"10.18632\/oncotarget.10614","volume":"7","author":"RM Hallett","year":"2016","unstructured":"Hallett RM, Girgis-Gabardo A, Gwynne WD, Giacomelli AO, Bisson JN, Jensen JE, Dvorkin-Gheva A, Hassell JA (2016) Serotonin transporter antagonists target tumor-initiating cells in a transgenic mouse model of breast cancer. Oncotarget 7:53137\u201353152","journal-title":"Oncotarget"},{"key":"15_CR11","doi-asserted-by":"publisher","first-page":"8052","DOI":"10.18632\/oncotarget.2408","volume":"5","author":"RE Kast","year":"2014","unstructured":"Kast RE, Karpel-Massler G, Halatsch ME (2014) CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide. Oncotarget 5:8052\u20138082","journal-title":"Oncotarget"},{"key":"15_CR12","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1248\/bpb.b15-00128","volume":"38","author":"J Kuwahara","year":"2015","unstructured":"Kuwahara J, Yamada T, Egashira N, Ueda M, Zukeyama N, Ushio S, Masuda S (2015) Comparison of the anti-tumor effects of selective serotonin reuptake inhibitors as well as serotonin and norepinephrine reuptake inhibitors in human hepatocellular carcinoma cells. Biol Pharm Bull 38:1410\u20131414","journal-title":"Biol Pharm Bull"},{"key":"15_CR13","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1158\/0008-5472.CAN-09-4072","volume":"70","author":"CJ Lin","year":"2010","unstructured":"Lin CJ, Robert F, Sukarieh R, Michnick S, Pelletier J (2010) The antidepressant sertraline inhibits translation initiation by curtailing mammalian target of rapamycin signaling. Cancer Res 70:3199\u20133208","journal-title":"Cancer Res"},{"key":"15_CR14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1021\/pr9001367","volume":"9","author":"Q Ma","year":"2010","unstructured":"Ma Q, Geng Y, Xu W, Wu Y, He F, Shu W, Huang M, Du H, Li M (2010) The role of translationally controlled tumor protein in tumor growth and metastasis of colon adenocarcinoma cells. J Proteome Res 9:40\u201349","journal-title":"J Proteome Res"},{"key":"15_CR16","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1126\/science.7542803","volume":"269","author":"SM MacDonald","year":"1995","unstructured":"MacDonald SM, Rafnar T, Langdon J, Lichtenstein LM (1995) Molecular identification of an IgE-dependent histamine-releasing factor. Science 269:688\u2013690","journal-title":"Science"},{"key":"15_CR15","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nchembio790","volume":"2","author":"ML MacDonald","year":"2006","unstructured":"MacDonald ML, Lamerdin J, Owens S, Keon BH, Bilter GK, Shang Z, Huang Z, Yu H, Dias J, Minami T et al (2006) Identifying off-target effects and hidden phenotypes of drugs in human cells. Nat Chem Biol 2:329\u2013337","journal-title":"Nat Chem Biol"},{"key":"15_CR17","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.ccr.2012.11.002","volume":"22","author":"D Nagel","year":"2012","unstructured":"Nagel D, Spranger S, Vincendeau M, Grau M, Raffegerst S, Kloo B, Hlahla D, Neuenschwander M, Peter von Kries J, Hadian K et al (2012) Pharmacologic inhibition of MALT1 protease by phenothiazines as a therapeutic approach for the treatment of aggressive ABC-DLBCL. Cancer Cell 22:825\u2013837","journal-title":"Cancer Cell"},{"key":"15_CR18","first-page":"63","volume":"5","author":"KM Niforou","year":"2008","unstructured":"Niforou KM, Anagnostopoulos AK, Vougas K, Kittas C, Gorgoulis VG, Tsangaris GT (2008) The proteome profile of the human osteosarcoma U2OS cell line. Cancer Genomics Proteomics 5:63\u201378","journal-title":"Cancer Genomics Proteomics"},{"key":"15_CR19","doi-asserted-by":"publisher","first-page":"9064","DOI":"10.1073\/pnas.89.19.9064","volume":"89","author":"OW Petersen","year":"1992","unstructured":"Petersen OW, Ronnov-Jessen L, Howlett AR, Bissell MJ (1992) Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc Natl Acad Sci U S A 89:9064\u20139068","journal-title":"Proc Natl Acad Sci U S A"},{"key":"15_CR20","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1073\/pnas.60.1.126","volume":"60","author":"RE Pollack","year":"1968","unstructured":"Pollack RE, Green H, Todaro GJ (1968) Growth control in cultured cells: selection of sublines with increased sensitivity to contact inhibition and decreased tumor-producing ability. Proc Natl Acad Sci U S A 60:126\u2013133","journal-title":"Proc Natl Acad Sci U S A"},{"key":"15_CR21","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/bjc.1984.207","volume":"50","author":"A Ramu","year":"1984","unstructured":"Ramu A, Spanier R, Rahamimoff H, Fuks Z (1984) Restoration of doxorubicin responsiveness in doxorubicin-resistant P388 murine leukaemia cells. Br J Cancer 50:501\u2013507","journal-title":"Br J Cancer"},{"key":"15_CR22","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.cell.2012.03.049","volume":"149","author":"E Sachlos","year":"2012","unstructured":"Sachlos E, Risueno RM, Laronde S, Shapovalova Z, Lee JH, Russell J, Malig M, McNicol JD, Fiebig-Comyn A, Graham M et al (2012) Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells. Cell 149:1284\u20131297","journal-title":"Cell"},{"key":"15_CR23","first-page":"4201","volume":"31","author":"G Spengler","year":"2011","unstructured":"Spengler G, Molnar J, Viveiros M, Amaral L (2011) Thioridazine induces apoptosis of multidrug-resistant mouse lymphoma cells transfected with the human ABCB1 and inhibits the expression of P-glycoprotein. Anticancer Res 31:4201\u20134205","journal-title":"Anticancer Res"},{"key":"15_CR24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S1570-9639(03)00204-8","volume":"1650","author":"R Stierum","year":"2003","unstructured":"Stierum R, Gaspari M, Dommels Y, Ouatas T, Pluk H, Jespersen S, Vogels J, Verhoeckx K, Groten J, van Ommen B (2003) Proteome analysis reveals novel proteins associated with proliferation and differentiation of the colorectal cancer cell line Caco-2. Biochim Biophys Acta 1650:73\u201391","journal-title":"Biochim Biophys Acta"},{"key":"15_CR25","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/cdd.2008.18","volume":"15","author":"L Susini","year":"2008","unstructured":"Susini L, Besse S, Duflaut D, Lespagnol A, Beekman C, Fiucci G, Atkinson AR, Busso D, Poussin P, Marine JC et al (2008) TCTP protects from apoptotic cell death by antagonizing bax function. Cell Death Differ 15:1211\u20131220","journal-title":"Cell Death Differ"},{"key":"15_CR26","doi-asserted-by":"publisher","first-page":"19725","DOI":"10.1038\/srep19725","volume":"6","author":"S Thebault","year":"2016","unstructured":"Thebault S, Agez M, Chi X, Stojko J, Cura V, Telerman SB, Maillet L, Gautier F, Billas-Massobrio I, Birck C et al (2016) TCTP contains a BH3-like domain, which instead of inhibiting, activates Bcl-xL. Sci Rep 6:19725","journal-title":"Sci Rep"},{"key":"15_CR28","doi-asserted-by":"publisher","first-page":"14976","DOI":"10.1073\/pnas.222470799","volume":"99","author":"M Tuynder","year":"2002","unstructured":"Tuynder M, Susini L, Prieur S, Besse S, Fiucci G, Amson R, Telerman A (2002) Biological models and genes of tumor reversion: cellular reprogramming through tpt1\/TCTP and SIAH-1. Proc Natl Acad Sci U S A 99:14976\u201314981","journal-title":"Proc Natl Acad Sci U S A"},{"key":"15_CR27","doi-asserted-by":"publisher","first-page":"15364","DOI":"10.1073\/pnas.0406776101","volume":"101","author":"M Tuynder","year":"2004","unstructured":"Tuynder M, Fiucci G, Prieur S, Lespagnol A, Geant A, Beaucourt S, Duflaut D, Besse S, Susini L, Cavarelli J et al (2004) Translationally controlled tumor protein is a target of tumor reversion. Proc Natl Acad Sci U S A 101:15364\u201315369","journal-title":"Proc Natl Acad Sci U S A"},{"key":"15_CR29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1006\/excr.2000.5066","volume":"262","author":"AS Vercoutter-Edouart","year":"2001","unstructured":"Vercoutter-Edouart AS, Czeszak X, Crepin M, Lemoine J, Boilly B, Le Bourhis X, Peyrat JP, Hondermarck H (2001) Proteomic detection of changes in protein synthesis induced by fibroblast growth factor-2 in MCF-7 human breast cancer cells. Exp Cell Res 262:59\u201368","journal-title":"Exp Cell Res"},{"key":"15_CR30","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S1470-2045(06)70622-2","volume":"7","author":"W Xu","year":"2006","unstructured":"Xu W, Tamim H, Shapiro S, Stang MR, Collet JP (2006) Use of antidepressants and risk of colorectal cancer: a nested case-control study. Lancet Oncol 7:301\u2013308","journal-title":"Lancet Oncol"}],"container-title":["Results and Problems in Cell Differentiation","TCTP\/tpt1 - Remodeling Signaling from Stem Cell to Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-67591-6_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T10:06:20Z","timestamp":1558173980000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-67591-6_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9783319675909","9783319675916"],"references-count":30,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-67591-6_15","relation":{},"ISSN":["0080-1844","1861-0412"],"issn-type":[{"value":"0080-1844","type":"print"},{"value":"1861-0412","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]},"assertion":[{"value":"18 November 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}